{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T06:33:57Z","timestamp":1791182037684,"version":"4.1.0"},"reference-count":15,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2009,8,3]],"date-time":"2009-08-03T00:00:00Z","timestamp":1249257600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2009,8,3]],"date-time":"2009-08-03T00:00:00Z","timestamp":1249257600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1111\/j.1365-2133.2009.09434.x","type":"journal-article","created":{"date-parts":[[2009,8,3]],"date-time":"2009-08-03T16:25:05Z","timestamp":1249316705000},"page":"185-190","source":"Crossref","is-referenced-by-count":17,"title":["Effects of topical treatment with the raft modulator miltefosine and clobetasol in cutaneous mastocytosis: a randomized, double-blind, placebo-controlled trial"],"prefix":"10.1093","volume":"162","author":[{"given":"K.","family":"Hartmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Siebenhaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Belloni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Brockow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Eben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Ru\u00ebff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Schoepke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Staubach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Maurer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2009,8,3]]},"reference":[{"key":"10.1111\/j.1365-2133.2009.09434.x-BIB1|cit1","first-page":"291","volume-title":"World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Haematopoietic and Lymphoid Tissues","author":"Valent","year":"2001"},{"key":"10.1111\/j.1365-2133.2009.09434.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1159\/000101711","article-title":"Mastocytosis: state of the art","volume":"74","author":"Horny","year":"2007","journal-title":"Pathobiology"},{"key":"10.1111\/j.1365-2133.2009.09434.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2174\/187152806775269303","article-title":"Current options in the treatment of mast cell mediator-related symptoms in mastocytosis","volume":"5","author":"Escribano","year":"2006","journal-title":"Inflamm Allergy Drug Targets"},{"key":"10.1111\/j.1365-2133.2009.09434.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/jid.2008.248","article-title":"Miltefosine inhibits human mast cell activation and mediator release both in vitro and in vivo","volume":"129","author":"Weller","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09434.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1006\/smim.2000.0301","article-title":"Fc\u03b5RI as a paradigm for a lipid raft-dependent receptor in hematopoietic cells","volume":"13","author":"Holowka","year":"2001","journal-title":"Semin Immunol"},{"key":"10.1111\/j.1365-2133.2009.09434.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1194\/jlr.M600485-JLR200","article-title":"Fc\u03b5RI and Thy-1 domains have unique protein and lipid compositions","volume":"48","author":"Surviladze","year":"2007","journal-title":"J Lipid Res"},{"key":"10.1111\/j.1365-2133.2009.09434.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1158\/1535-7163.MCT-07-0202","article-title":"A new class of anticancer alkylphospholipids uses lipid rafts as membrane gateways to induce apoptosis in lymphoma cells","volume":"6","author":"Van der Luit","year":"2007","journal-title":"Mol Cancer Ther"},{"key":"10.1111\/j.1365-2133.2009.09434.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/j.bcp.2007.07.041","article-title":"Lipid rafts and metabolic energy differentially determine uptake of anti-cancer alkylphospholipids in lymphoma versus carcinoma cells","volume":"74","author":"Vink","year":"2007","journal-title":"Biochem Pharmacol"},{"key":"10.1111\/j.1365-2133.2009.09434.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1038\/sj.bjc.6690184","article-title":"Phase II trial of topically applied miltefosine solution in patients with skin-metastasized breast cancer","volume":"79","author":"Terwogt","year":"1999","journal-title":"Br J Cancer"},{"key":"10.1111\/j.1365-2133.2009.09434.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"4150","DOI":"10.1200\/JCO.2001.19.21.4150","article-title":"Randomized double-blind, placebo-controlled, multicenter trial of 6% miltefosine solution, a topical chemotherapy in cutaneous metastases from breast cancer","volume":"19","author":"Leonard","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1111\/j.1365-2133.2009.09434.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.4049\/jimmunol.135.4.2368","article-title":"Cutaneous mast cell depletion results from topical corticosteroid usage","volume":"135","author":"Lavker","year":"1985","journal-title":"J Immunol"},{"key":"10.1111\/j.1365-2133.2009.09434.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1172\/JCI119336","article-title":"Glucocorticoids decrease tissue mast cell number by reducing the production of the c-kit ligand, stem cell factor, by resident cells","volume":"99","author":"Finotto","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1365-2133.2009.09434.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/0091-6749(88)90015-2","article-title":"A survey of the number and distribution of mast cells in the skin of patients with mast cell disorders","volume":"82","author":"Garriga","year":"1988","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/j.1365-2133.2009.09434.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1067\/mai.2002.120524","article-title":"Levels of mast-cell growth factors in plasma and in suction skin blister fluid in adults with mastocytosis: correlation with dermal mast-cell numbers and mast-cell tryptase","volume":"109","author":"Brockow","year":"2002","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/j.1365-2133.2009.09434.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1046\/j.1365-2133.2003.05090.x","article-title":"Pattern analysis of human cutaneous mast cell populations by total body surface mapping","volume":"148","author":"Weber","year":"2003","journal-title":"Br J Dermatol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2009.09434.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2009.09434.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2133.2009.09434.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T06:27:37Z","timestamp":1685082457000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/162\/1\/185\/6642687"}},"subtitle":["Miltefosine in cutaneous mastocytosis"],"short-title":[],"issued":{"date-parts":[[2009,8,3]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2133.2009.09434.x","archive":["Portico"],"relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2009,8,3]]}}}